Yellow Fever Virus


KU Leuven Breakthrough as Modified Yellow Fever Virus Destroys COVID-19 in Preclinical Animal Research: Clinical Trials Next

Thus far, the Rega Institute at the Belgian university KU Leuven has produced promising results in preclinical (animal) research evaluating a modified yellow fever vaccine targeting COVID-19. They report that once the modified investigational product—derived from the...

Pin It on Pinterest